Aristeia Capital’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Aristeia Capital’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-125,000	Closed	-$5.98K	–	385
2023 Q1	$5.98K	Hold	125,000	–	–	﹤0.01%	374
2022 Q4	$3.24K	Hold	125,000	–	–	﹤0.01%	499
2022 Q3	$13K	Hold	125,000	–	–	﹤0.01%	634
2022 Q2	$18K	Hold	125,000	–	–	﹤0.01%	639
2022 Q1	$35K	Buy	+125,000	New	+$45.6K	﹤0.01%	678

Aristeia Capital's IQMDW Position: Q2 2023 in Review

Aristeia Capital sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 125,000 shares — an estimated $5.98K sold.

Aristeia Capital first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $35K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Aristeia Capital reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Aristeia Capital sold 125,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $5.98K.
Aristeia Capital first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
Aristeia Capital's Intelligent Medicine Acquisition Corp. Warrant position peaked at $35K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Aristeia Capital's 13F filing for Q2 2023, filed 14 Aug 2023.